Published online Sep 28, 2023. doi: 10.3748/wjg.v29.i36.5254
Peer-review started: July 20, 2023
First decision: August 5, 2023
Revised: August 11, 2023
Accepted: September 8, 2023
Article in press: September 8, 2023
Published online: September 28, 2023
Processing time: 61 Days and 22.2 Hours
Barrier surfaces composed of specialized epithelial cells separate the host body from the external environment, and are essential for maintaining proper intestinal physiologic and immune homeostasis. There is growing evidence that the mucosal healing and reestablishment of barrier integrity are significantly associated with clinical remission and improved patient outcomes.
With the rapid expansion of research topics, it has become challenging for researchers to accumulate knowledge and actively collect evidence in specific field. The bibliographic and visual analysis provides new angles to identify development trends and predict research prospects of this field by mathematics and statistics.
The purpose of this study was to provide a comprehensive overview of the knowledge structure and research hotspots of intestinal barrier in inflammatory bowel disease (IBD).
The publications related to intestinal barrier in IBD were obtained from the Web of Science Core Collection database. Bibliometric analysis and visualization were conducted using VOSviewer, CiteSpace and R software.
A comprehensive analysis of 4482 articles published between 2002 and 2022 has revealed significant insights in the realm of intestinal barrier research. Intestinal barrier research mainly focuses on four aspects, including clinical characteristics, barrier function, gut microbiota, and inflammation regulation. The keywords appearing at high frequency related with intestinal barrier in IBD were detected, including nuclear factor kappa B, tumor necrosis factor-α, apoptosis, oxidative stress and probiotics. Among them, antioxidants, Akkermansia muciniphila, nanoparticles, short-chain fatty acids and extracellular vesicles have received extensive interest in current research.
The intestinal barrier field is developing rapidly with extensive cooperation. Targeting the gut microbiota and dietary metabolism to regulate intestinal barrier shown promising applied prospective and has generated broad interest.
The importance of the intestinal barrier in IBD is gradually being fully recognized, providing a new therapeutic perspective for improving inflammation.